MYGN
#2816
Myriad Genetics, Inc. - Common Stock
6.1 7 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.22%
Monthly Change
+44.84%
6 month change
+2.83%
Year Change
-25.39%
Previous Close
6.3 1
Open
6.2 0
Low
6.1 6
High
6.2 1
Volume
124
Financials
- Market Capitalization 582.75 M
- Employee 2 700
- Founded 1991
- CEO Paul J. DiazPaul J. Diaz
- Website www.myriad.com
- Headquarter Delaware, United States
- FIGI BBG000D9H9F1
- Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.04
Price to sales ratio
0.5
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2659 |  ACRS Aclaris Therapeutics, Inc. - Common Stock | 5.35 USD | -4.46% | -7.28% | +23.84% | +240.76% | 747.20 M USD | ||
| 2809 |  FLGT Fulgent Genetics, Inc. - Common Stock | 20.67 USD | -1.62% | -0.72% | +15.28% | -12.53% | 587.04 M USD | ||
| 3218 |  LAB Standard BioTools Inc. - Common Stock | 0.88 USD | +4.76% | -4.35% | +4.76% | -28.46% | 343.26 M USD | ||
| 3336 |  PRE Prenetics Global Limited - Class A Ordinary Share | 17.77 USD | -9.24% | -1.06% | -13.91% | +109.06% | 299.85 M USD |
Frequently asked questions about Myriad Genetics, Inc. - Common Stock
What is the Myriad Genetics, Inc. - Common Stock stock price today?
The current price of Myriad Genetics, Inc. - Common Stock (MYGN) is 6.17. Over the past 24 hours, the stock has changed by -2.22%. Follow the MYGN chart for real-time price dynamics.
What is the stock ticker of Myriad Genetics, Inc. - Common Stock?
Myriad Genetics, Inc. - Common Stock trades under the ticker MYGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Myriad Genetics, Inc. - Common Stock stock going up?
MYGN has changed by +1.31% over the last week, +44.84% over the last month, and -25.39% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Myriad Genetics, Inc. - Common Stock net income for the last quarter?
Myriad Genetics, Inc. - Common Stock reported net income of -34.1 M for the last quarter. The previous quarter showed -7.9 M, which means net income changed by -331.65%.
How many employees does Myriad Genetics, Inc. - Common Stock have?
As of the latest available data, Myriad Genetics, Inc. - Common Stock has 2 700 employees. Workforce size can provide additional context about the company's scale and operations.
What is Myriad Genetics, Inc. - Common Stock EBITDA?
Myriad Genetics, Inc. - Common Stock EBITDA is -18.1 M, and its EBITDA margin is -9.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Myriad Genetics, Inc. - Common Stock stock?
You can buy Myriad Genetics, Inc. - Common Stock (MYGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Myriad Genetics, Inc. - Common Stock stock?
Investing in Myriad Genetics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MYGN chart and related analysis on metatrader.com as part of your research.